A Single-Arm Exploratory Study of Enlansibumab Sequentially Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Clinical trial NCT06981858 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06981858
- Sponsor
- Chongqing University Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-15
- Primary completion
- 2029-02-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.